The dynamic biliary epithelia: Molecules, pathways, and disease

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Don C. Rockey  Clinical Gastroenterology and Hepatology 
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Tiny RNA with great effects: miR-155 in alcoholic liver disease
The role of Epstein–Barr virus in acute and chronic hepatitis
Pathways of liver injury in alcoholic liver disease
Update on primary sclerosing cholangitis
The inflammasome in liver disease
Anatoliy I. Masyuk, Tatyana V. Masyuk, Nicholas F. LaRusso 
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 57, Issue 1, Pages 6-8 (July 2012)
Don C. Rockey  Clinical Gastroenterology and Hepatology 
Hedgehog signaling in the liver
Agustín Albillos, Margaret Lario, Melchor Álvarez-Mon 
The gut microbiota and the liver
Roles for Chemokines in Liver Disease
Gut–liver immunity Journal of Hepatology
Mechanisms of Hepatic Fibrogenesis
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
The role of Epstein–Barr virus in acute and chronic hepatitis
The progenitor cell dilemma: Cellular and functional heterogeneity in assistance or escalation of liver injury  Veronika Lukacs-Kornek, Frank Lammert 
Marina Berenguer, Detlef Schuppan  Journal of Hepatology 
Targeting the gut-liver axis in liver disease
Inflammation and portal hypertension – The undiscovered country
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study.
I. Carmona, P. Cordero, J. Ampuero, A. Rojas, M. Romero-Gómez 
The quest for liver progenitor cells: A practical point of view
Targeting gut flora to prevent progression of hepatocellular carcinoma
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts  Chiara Raggi, Pietro Invernizzi,
Ariane Mallat, Sophie Lotersztajn  Journal of Hepatology 
Autophagy and senescence in fibrosing cholangiopathies
Genomic risk of hepatitis C-related hepatocellular carcinoma
Volume 59, Issue 3, Pages (September 2013)
Sinusoidal communication in liver fibrosis and regeneration
Pathways of liver injury in alcoholic liver disease
Emina Halilbasic, Thierry Claudel, Michael Trauner 
EASL Clinical Practice Guidelines: Wilson’s disease
Veronika Lukacs-Kornek, Detlef Schuppan  Journal of Hepatology 
Volume 66, Issue 1, Pages (January 2017)
F. Berenbaum  Osteoarthritis and Cartilage 
Cannabinoid signaling and liver therapeutics
Volume 63, Issue 2, Pages (August 2015)
Karel J. van Erpecum, Frank G. Schaap  Journal of Hepatology 
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Salvatore Papa, Concetta Bubici  Journal of Hepatology 
The potential of induced pluripotent stem cell derived hepatocytes
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Macrophage heterogeneity in liver injury and fibrosis
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Tatiana Kisseleva, David A. Brenner  Journal of Hepatology 
Volume 65, Issue 4, Pages (October 2016)
Volume 134, Issue 1, Pages 8-14 (January 2008)
Statins: Old drugs as new therapy for liver diseases?
Inflammation in Wound Repair: Molecular and Cellular Mechanisms
Pathogenesis of cholestatic hepatitis C
The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved?  Mario Strazzabosco, Luca Fabris 
Inflammatory pathways in alcoholic steatohepatitis
Microbiome as a therapeutic target in alcohol-related liver disease
Foxa1 and Foxa2 regulate bile duct development in mice
Volume 61, Issue 2, Pages (August 2014)
Nathalie Ganne-Carrié, Pierre Nahon  Journal of Hepatology 
Platelets arrive at the scene of fibrosis……studies
Niya Aleksieva, Stuart J. Forbes  Journal of Hepatology 
Presentation transcript:

The dynamic biliary epithelia: Molecules, pathways, and disease Steven P. O’Hara, James H. Tabibian, Patrick L. Splinter, Nicholas F. LaRusso  Journal of Hepatology  Volume 58, Issue 3, Pages 575-582 (March 2013) DOI: 10.1016/j.jhep.2012.10.011 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 The role of cholangiocytes in cholangiopathies. Cholangiocytes recognize potential insults (endogenous or exogenous) and respond through the upregulation of proinflammatory mediators. These features are a component of the intricate crosstalk between a variety of resident and recruited cells, including hepatocytes, progenitor cells, fibroblasts and leukocytes, in an attempt to repair the epithelium. In most cases, the proinflammatory response and injury/damage to the biliary tree is resolved. However, in the genetically susceptible individual, perpetuation of the repair response results in progressive liver injury and a persistent inflammatory response, leading to chronic inflammation of the bile ducts and ultimately, disease. Journal of Hepatology 2013 58, 575-582DOI: (10.1016/j.jhep.2012.10.011) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Cholangiocytes exist in an environment rich of potential mediators of cellular injury. Through enterohepatic circulation: (1) the liver is exposed to bacterially derived products (PAMPs), xenobiotics and endogenous mediators of inflammation (DAMPs). Portal blood flows into hepatic sinusoids, where a variety of resident and recruited cells can recognize and respond to these potential insults. Ultimately, hepatocytes take up, modify, and excrete these molecules into the canaliculus. Canalicular bile percolates through the biliary tree where cholangiocytes recognize and react to these potential insults through the increased release and response to repair associated chemokines/cytokines, growth factors, and morphogens, initiating both autocrine and paracrine signaling cascades (2). A more comprehensive understanding of the role of the gut in hepatic function and the molecular networks mediating injury induced growth and repair, as well as the cholangiocyte epigenetic phenomena, and the genetic variation (3) that contribute to the perpetuation of this phenotype and sequelae, including fibrogenesis and carcinogenesis, will undoubtedly open avenues for potential therapeutic approaches. Journal of Hepatology 2013 58, 575-582DOI: (10.1016/j.jhep.2012.10.011) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions